Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Feinstein Institute, Journal of Internal Medicine, Karolinska Institutet, the Royal Swedish Academy of Sciences, and the New York Academy of Sciences Host Symposium about Bioelectronic Medicine

Four venerable scientific organizations will bring together experts to discuss the technological promise of a groundbreaking new field.

Published September 08, 2016

New York, September 8, 2016 — On September 21–23, 2016 The Feinstein Institute for Medical Research, the Journal of Internal Medicine (JIM), Karolinska Institutet, the Royal Swedish Academy of Sciences, and the New York Academy of Sciences will jointly present the 13th Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms. Held at the New York Academy of Sciences in Manhattan, this event will bring together experts from the fields of healthcare, technology, and science to share knowledge and answer key questions about this groundbreaking new discipline aimed at interfacing electronics with cells to target molecular mechanisms.

Bioelectronic medicine, this year's symposium topic, identifies targets of disease or health, the neural pathway that manages this function and then uses technology to produce therapeutic benefit. The promise of this research is safe and economical alternatives to pills and injectables.

In its thirteenth year, the Key Symposium, sponsored by JIM and the Royal Swedish Academy of Sciences, was created to provide a forum to discuss the emerging topics within clinical medicine. This is only the second time that a US-based organization has been asked to host the event (all previous events took place in Europe).

"We are honored to be asked to host this year's Key Symposium on bioelectronic medicine — a major area of study for our organization," says Kevin J. Tracey, MD, president and CEO, The Feinstein Institute for Medical Research. "Bioelectronic medicine aims to harness the power of technology to decode our nervous system so the body can heal itself. Through an open dialog between leaders in all related areas of study, we hope to spur further inspiration, research collaboration and discovery."

At the symposium, experts will discuss: Defining Circuits, Cell Biology and Cancer, Molecular Sensing, Clinical Updates, Brain Interfaces, Processing the Future, and Funding the Field.

"JIM is happy to support the 13th Key Symposium on bioelectronic medicine," says Ulf de Faire, MD, PhD, editor-in-chief, JIM. "In previous years we have covered a broad range of topics including Alzheimer's disease, biology of aging, taming of the cancer cell and other translational topics. The current symposium on bioelectronic medicine fits perfectly into the primary aims of these event; to better understand the fine-tuned interplay between molecular mechanisms and clinical outcome; knowledge needed to be able to further advance options for treatment and prevention. We look forward to participating in this exciting meeting."

For media inquiries, including requests for press passes, contact Margaret Ceres (; 212.298.8612).

About The Feinstein Institute

The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the 2,000 researchers and staff of the Feinstein are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine — a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit

About Journal of Internal Medicine

Journal of Internal Medicine (JIM) was established in 1863, and with an Impact Factor of 7.803, JIM now ranks 10th among the 151 journals in the General & Internal Medicine category.

The Journal features original clinical articles within the broad field of general and internal medicine and its sub-specialties and is a fully international journal publishing articles in English from all over the world. All articles are peer-reviewed and published in both print and online versions.

JIM also supports and organizes scientific meetings in the form of symposia within the scope of the journal.

About The Royal Swedish Academy of Sciences

The Royal Swedish Academy of Sciences is an independent, nongovernmental organisation with a charter that, in its first article, defines its function as promoting the sciences and strengthening their influence in society.

The Academy promotes science of the highest quality by fostering development and innovation in Swedish research. It enhances the status of science in society by drawing attention to key social issues, examining them in scientific terms and communicating the results, and joins in cooperation on global issues, with the aim of being an international scientific proponent of sustainable development. Every year the Academy awards the Nobel Prizes in Physics and Chemistry, the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel, the Crafoord Prize and a number of other large prizes.

About Karolinska Institutet

Karolinska Institutet is one of the world's leading medical universities. Its vision is to significantly contribute to the improvement of human health. Karolinska Institutet accounts for over 40 percent of the medical academic research conducted in Sweden and offers the country's broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.

About the New York Academy of Sciences

The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With more than 20,000 members in 100 countries around the world, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at


Marie Gentile
Director, Communications